ANA5 Funnel Catheter

Organization
Anaconda Biomed · Spain
Solution Type
Ready Product / Solution
Collaboration
Business Collaboration (Joint Venture), Licensing

1. Technology overview

Anaconda Biomed is a medical technology company based in Sant Quirze del Valles, Barcelona, Spain (Carrer d'Eivissa 56), with a US presence in Marin, California. It develops thrombectomy catheters for ischemic stroke and other neurovascular disease.

The ANA5 is a sterile, single-use, self-expanding funnel catheter for mechanical thrombectomy. Its funnel-shaped tip combines aspiration with flow-arrest and flow-reversal to capture clots and limit embolic complications. The company reports CE Mark certification for ANA5 (announced June 2025) and notes the device is investigational in the United States while a randomized 327-subject pivotal study (ATHENA) proceeds.

2. Highlighted features & specifications

  • Funnel geometry: self-expanding funnel tip designed to capture clots.
  • Combined mechanism: aspiration with flow-arrest and flow-reversal.
  • Size range: ANA5, ANA6 and ANA8 catheters.
  • Conda stent retriever: complementary device in the portfolio.
  • Single use: sterile, disposable catheter.
  • Evidence: ATHENA randomized pivotal study of 327 subjects.

3. Potential application

Neurointerventional departments at Vietnamese stroke centers can evaluate the catheter for large vessel occlusion thrombectomy. Distributors of neurovascular devices can add it to portfolios where CE marking is accepted. Hospitals can use it in stroke-network training programs.

4. Benefits

Aims to maximize clot capture and improve first-pass recanalization in stroke thrombectomy. Combines aspiration with flow-arrest and flow-reversal to reduce embolic complications. Single-use sterile device with CE Mark for commercial distribution in Europe. Part of a growing portfolio of ANA5, ANA6, ANA8 and a stent retriever.

6. Other information

Headquarters and production near Barcelona; US presence in Marin, California. September 2026 financing led by Omega Funds with FOCO, Asabys, Ysios Capital and CDTI. First US ATHENA patient enrolled April 2025. Listed among EIC Scaling Club healthtech scaleups by third-party coverage; EIC not stated on the vendor site.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us